Affect of genetic polymorphisms on pain perception and pain management in lung cancer survivors

Shailendra Kapoor, MD

doi:10.5055/jom.2012.0108

Authors

Shailendra Kapoor, MD

DOI:

https://doi.org/10.5055/jom.2012.0108

Abstract

no abstract

Author Biography

Shailendra Kapoor, MD

Private practice, Mechanicsville, Virginia

References

Simone CB II, Vapiwala N, Hampshire MK, et al.: Palliative care in the management of lung cancer: Analgesic utilization and barriers to optimal pain management. J Opioid Manag. 2012; 8: 9-16.

Rausch SM, Gonzalez BD, Clark MM, et al.: SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. Lung Cancer. 2012 (in press).

Reyes-Gibby CC, Spitz MR, Yennurajalingam S, et al.: Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2636-2642.

Reyes-Gibby CC, El Osta B, Spitz MR, et al.: The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3262-3267.

Reyes-Gibby CC, Spitz M, Wu X, et al.: Cytokine genes and pain severity in lung cancer: Exploring the influence of TNFalpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2745-2751.

Daniel M, Keefe FJ, Lyna P, et al.: Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009; 10: 323-328.